
|Videos|September 10, 2021
Comparison of suitable naïve versus pretreated DMO patients
Author(s)OTE Staff Reports
Dr Javier Zarranz-Ventura discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pretreated DMO patients, and what it means for future research.
Advertisement
Dr Javier Zarranz-Ventura, a vitreoretinal consultant at
Institut Clínic de Oftalmologia (ICOF), Hospital Clínic de Barcelona andInstitut de Investigacions Biomediques August Pi i Sunyer (IDIBAPS), discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pretreated DMO patients, and what it means for future research.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
DEX implant shows benefit across RVO subgroups in real-world retrospective study
2
European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease
3
Lumvoa gains US FDA approval for thyroid eye disease with class-first broad label
4
Study examines accommodation after iris-fixated phakic IOL implantation
5

























